On Monday, Aytu BioPharma Inc (NASDAQ: AYTU) was 15.26% up from the session before settling in for the closing price of $1.9. A 52-week range for AYTU has been $0.95 – $2.82.
Healthcare Sector giant saw their annual sales surged by 48.61% over the last five years. When this article was written, the company’s average yearly earnings per share was at 47.79%. With a float of $8.67 million, this company’s outstanding shares have now reached $8.98 million.
Aytu BioPharma Inc (AYTU) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Aytu BioPharma Inc stocks. The insider ownership of Aytu BioPharma Inc is 12.52%, while institutional ownership is 34.47%. The most recent insider transaction that took place on Jun 09 ’25, was worth 24,999. In this transaction Chief Business Officer of this company bought 16,666 shares at a rate of $1.50, taking the stock ownership to the 29,462 shares. Before that another transaction happened on Jun 09 ’25, when Company’s Chief Executive Officer bought 66,666 for $1.50, making the entire transaction worth $99,999. This insider now owns 153,257 shares in total.
Aytu BioPharma Inc (AYTU) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.15 earnings per share (EPS) during the time that was better than consensus figure (set at -0.34) by 0.19. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.61 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 47.79% per share during the next fiscal year.
Aytu BioPharma Inc (NASDAQ: AYTU) Trading Performance Indicators
You can see what Aytu BioPharma Inc (AYTU) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.07. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.33.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.81, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.07 in one year’s time.
Technical Analysis of Aytu BioPharma Inc (AYTU)
Analysing the last 5-days average volume posted by the [Aytu BioPharma Inc, AYTU], we can find that recorded value of 0.31 million was lower than the volume posted last year of 0.54 million. As of the previous 9 days, the stock’s Stochastic %D was 50.39%.
During the past 100 days, Aytu BioPharma Inc’s (AYTU) raw stochastic average was set at 58.00%, which indicates a significant increase from 53.46% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1600 in the past 14 days, which was higher than the 0.1600 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.2600, while its 200-day Moving Average is $1.7700. Now, the first resistance to watch is $2.2900. This is followed by the second major resistance level at $2.3800. The third major resistance level sits at $2.5500. If the price goes on to break the first support level at $2.0300, it is likely to go to the next support level at $1.8600. Now, if the price goes above the second support level, the third support stands at $1.7700.
Aytu BioPharma Inc (NASDAQ: AYTU) Key Stats
There are 9,912K outstanding shares of the company, which has a market capitalization of 21.71 million. As of now, sales total 66,380 K while income totals -13,560 K. Its latest quarter income was 15,140 K while its last quarter net income were -19,820 K.
